Stockreport

Better Buy: Editas Medicine vs. Intellia [The Motley Fool]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF Investors looking for high-growth, high-risk investments in the most cutting-edge areas of biotech should consider the world of gene editing. While there aren't many com [Read more]